GlassScriptPhysician profile
Jamie Ryan Jordan
NPI 1649261520
$3,440.22
in general payments reported to CMS, 2019-2025
23 companies · $499 in 2025
The $499 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,126 · 2020: $289 · 2021: $260 · 2022: $117 · 2023: $582 · 2024: $566 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,578 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,577.67 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $640.50 | 2019-2023 | Ensite Precision |
| E.R. Squibb & Sons, L.L.C. | $355.56 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $310.95 | 2019-2025 | |
| Medtronic Vascular, INC. | $261.74 | 2019-2020 | |
| Atricure, INC. | $234.02 | 2024 | |
| Boston Scientific Corporation | $206.02 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $175.59 | 2019-2023 | |
| Shockwave Medical, INC | $174.15 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cvrx, INC. | $165.87 | 2023-2024 | Barostim Neo System |
| Amgen INC. | $139.53 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $110.28 | 2019-2024 | |
| Biosense Webster, INC. | $97.80 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $90.20 | 2025 | Wainua, Farxiga |
| Medtronic, INC. | $89.53 | 2022-2023 | Selectsecure |
| Bridgebio Pharma, INC. | $84.60 | 2025 | Attruby |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $72.26 | 2021-2024 | Xarelto |
| Philips North America LLC | $59.50 | 2019 | |
| Lundbeck LLC | $44.45 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $38.11 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.44 | 2025 | |
| Esperion Therapeutics, INC. | $25.63 | 2021 | |
| Portola Pharmaceuticals, LLC | $17.39 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Jordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.